DavidAMorrowMDMPH

Cardiac Critical Care

Professor of Medicine, Brigham and Women's Hospital

Dr. Morrow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
75 Francis St
Cardiovascular Division
Boston, MA 02115
Phone+1 857-307-4000

Dr. David Morrow is a cardiologist in Boston, MA and is affiliated with Brigham and Women's Hospital. He received his medical degree from Harvard Medical School and has been in practice 23 years. He specializes in adult heart disease and cardiac critical care and is experienced in critical care medicine.

Regional Top Doctor Castle Connolly, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (FACC) American College of Cardiology

PubMed

Using Selection Criteria From the DanGer Shock Trial in a Contemporary Cohort With Cardiogenic Shock.
Connor G O'Brien, Samuel B Brusca, Christopher F Barnett, David D Berg, Vivian M Baird-Zars
Journal of the American College of Cardiology. 2024-12-17
Diverse NKT cells regulate early inflammation and neurological outcomes after cardiac arrest and resuscitation.
Tomoyoshi Tamura, Changde Cheng, Ana B Villaseñor-Altamirano, Kohei Yamada, Kohei Ikeda
Science Translational Medicine. 2024-12-04
1 citations
Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF Trial.
Marat Fudim, Derek D Cyr, Jonathan H Ward, Adrian F Hernandez, Serge Lepage
Journal of Cardiac Failure. 2024-12-01

Journal Articles

Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
Eugene Braunwald, David A Morrow, The New England Journal of Medicine

Lectures

Effect of Sacubitril/Valsartan on Biomarkers of Myocardial Stress in Patients Hospitalized With Acute Heart Failure in PIONEER-HF
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
High Sensitivity Troponin - Ready for Prime Time?
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Ranolazine Reduces Recurrent Ischemia in Patients with Non-ST Elevation ACS
56th Annual Scientific Session & Expo, New Orleans, Louisiana, USA
Evaluation of a Novel Antiplatelet Agent for Secondary Prevention in Patients With Atherosclerotic Disease: Results from the TRA 2P-TIMI 50 Trial
61st Annual Scientific Session & Expo, Chicago, Illinois, USA
Ranolazine Reduces Recurrent Ischemia in Patients with Non-ST Elevation ACS
American College of Cardiology, 56th Annual Scientific Session & Expo, New Orleans, Louisiana, USA
Evaluation of a Novel Antiplatelet Agent for Secondary Prevention in Patients With Atherosclerotic Disease: Results from the TRA 2P-TIMI 50 Trial
American College of Cardiology, 61st Annual Scientific Session & Expo, Chicago, Illinois, USA
Enoxaparin Continues to Show Clinical Benefit Vs Unfractionated Heparin for STEMI
ESC Congress 2007, Vienna, Austria
Enoxaparin Continues to Show Clinical Benefit Vs Unfractionated Heparin for STEMI
European Society of Cardiology, ESC Congress 2007, Vienna, Austria
Join now to see all

Other

C-reactive protein in cardiovascular disease
Morrow DA
http://www.uptodate.com/contents/c-reactive-protein-in-cardiovascular-disease
UpToDate, Wolters Kluwer Health - 2013-01-16
Screening for cardiovascular risk with C-reactive protein
Morrow DA
http://www.uptodate.com/contents/screening-for-cardiovascular-risk-with-c-reactive-protein
UpToDate, Wolters Kluwer Health - 2013-01-16
Troponins and creatine kinase as biomarkers of cardiac injury
Morrow DA, Jaffe AS
http://www.uptodate.com/contents/troponins-and-creatine-kinase-as-biomarkers-of-cardiac-injury
UpToDate, Wolters Kluwer Health - 2012-09-18
Periprocedural myocardial infarction following percutaneous coronary intervention
Morrow DA, Faxon DP, Holmes DR
http://www.uptodate.com/contents/periprocedural-myocardial-infarction-following-percutaneous-coronar
UpToDate, Wolters Kluwer Health - 2012-12-18
Elevated cardiac troponin concentration in the absence of an acute coronary syndrome
Morrow DA, Gibson CM
http://www.uptodate.com/contents/elevated-cardiac-troponin-concentration-in-the-absence-of-an-acute-
UpToDate, Wolters Kluwer Health - 2012-07-11
Join now to see all

Management of Ischaemic Stroke, Prognostic Impact of Procedural Myocardial Injury, and Antiplatelet Treatment: The Many Facets of Interventional CardiologyJanuary 30th, 2021
The Cardiac Care Unit SurvivalJune 27th, 2020
AHA: More Should Be Done for Seniors in Cardiac ICUDecember 9th, 2019
Join now to see all